维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Sarah E Ballatori"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Osteosarcoma:prognosis plateau warrants retinoblastoma pathway targeted therapy显示文摘Osteosarcoma(OS)is the most common primary bone cancer in children and adolescents,affecting~560 young patients in the United States annually.The term OS describes a diverse array of subtypes with varying prognoses,but the majority of tumors are high grade and aggressive.Perhaps because the true etiology of these aggressive tumors remains unknown,advances in OS treatment have reached a discouraging plateau,with only incremental improvements over the past 40 years.Thus,research surrounding the pathogenesis of OS is essential,as it promises to unveil novel therapeutic targets that can attack tumor cells with greater specificity and lower toxicity.Among the candidate molecular targets in OS,the retinoblastoma(RB)pathway demonstrates the highest frequency of inactivation and thus represents a particularly promising avenue for molecular targeted therapy.This review examines the present thinking and practices in OS treatment and specifically highlights the relevance of the RB pathway in osteosarcomagenesis.Through further investigation into RB pathway-related novel therapeutic targets,we believe that a near-term breakthrough in improved OS prognosis is possible.	Sarah E Ballatori Philip W Hinds	2016	Signal Transduction and Targeted Therapy2016，1，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费